(Updated - December 15, 2021 6:25 AM EST)

Wedbush analyst Andreas Argyrides assumes coverage on Kala Pharmaceuticals (NASDAQ: KALA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE